Sang Taek Jung

Affiliations: 
1993-1999 Chemical Technology Seoul National University, Seoul, South Korea 
 2004- Chemical Engineering University of Texas at Austin, Austin, Texas, U.S.A. 
 2011-2012 Chemistry and Chemical Engineering California Institute of Technology, Pasadena, CA 
 2012-2019 Bio and Nano Chemistry Kookmin University 
 2019- Department of Biomedical Sciences Korea University, Seoul, South Korea 
Website:
https://apel.korea.ac.kr/
Google:
"Sang Taek Jung"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
George Georgiou grad student 2004-2009 UT Austin
 (Engineering og Agylcosylated Antibody Fc for Effector Functions)
Frances H. Arnold post-doc 2010-2011 Caltech
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee W, Lee SM, Jung ST. (2023) Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Kim WS, Chae HD, Jung I, et al. (2023) Isolation and characterization of single domain antibodies from banded houndshark (Triakis scyllium) targeting SARS-CoV-2 spike RBD protein. Fish & Shellfish Immunology. 108807
Ha JY, Chun KJ, Ko S, et al. (2023) Glycan-Controlled Human PD-1 Variants Displaying Broad-Spectrum High Binding to PD-1 Ligands Potentiate T Cell. Molecular Pharmaceutics
Ko S, Ju MS, Ahn HM, et al. (2022) Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular Pharmaceutics
Kim WS, Kim JH, Lee J, et al. (2022) Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of . Bioengineering (Basel, Switzerland). 9
Ko S, Park S, Sohn MH, et al. (2022) An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies. Experimental & Molecular Medicine
Ju MS, Ahn HM, Han SG, et al. (2021) A human antibody against human endothelin receptor type A that exhibits antitumor potency. Experimental & Molecular Medicine
Ko S, Jo M, Jung ST. (2021) Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Ju MS, Jung ST. (2020) Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies. International Journal of Molecular Sciences. 21
Ko S, Jeon H, Yoon S, et al. (2020) Discovery of Novel Pseudomonas putida Flavin-Binding Fluorescent Protein Variants with Significantly Improved Quantum Yield. Journal of Agricultural and Food Chemistry
See more...